These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
7. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437 [TBL] [Abstract][Full Text] [Related]
10. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Senger DR; Perruzzi CA; Feder J; Dvorak HF Cancer Res; 1986 Nov; 46(11):5629-32. PubMed ID: 3756910 [TBL] [Abstract][Full Text] [Related]
11. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D J Exp Med; 1990 Dec; 172(6):1535-45. PubMed ID: 2258694 [TBL] [Abstract][Full Text] [Related]
12. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Roberts WG; Hasan T Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739 [TBL] [Abstract][Full Text] [Related]
13. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172 [TBL] [Abstract][Full Text] [Related]
14. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Brown LF; Tognazzi K; Dvorak HF; Harrist TJ Am J Pathol; 1996 Apr; 148(4):1065-74. PubMed ID: 8644848 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702 [TBL] [Abstract][Full Text] [Related]
16. Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Yeo TK; Senger DR; Dvorak HF; Freter L; Yeo KT Biochem Biophys Res Commun; 1991 Sep; 179(3):1568-75. PubMed ID: 1930196 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Collins PD; Connolly DT; Williams TJ Br J Pharmacol; 1993 May; 109(1):195-9. PubMed ID: 7684302 [TBL] [Abstract][Full Text] [Related]
18. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. Claffey KP; Senger DR; Spiegelman BM Biochim Biophys Acta; 1995 Jan; 1246(1):1-9. PubMed ID: 7811723 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. Tsai JC; Goldman CK; Gillespie GY J Neurosurg; 1995 May; 82(5):864-73. PubMed ID: 7714613 [TBL] [Abstract][Full Text] [Related]
20. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Kondo S; Matsumoto T; Yokoyama Y; Ohmori I; Suzuki H Biochim Biophys Acta; 1995 Feb; 1243(2):195-202. PubMed ID: 7533000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]